2,617
Views
1
CrossRef citations to date
0
Altmetric
Neurology

A prospective randomized comparison of the efficacy of standard antiviral therapy versus ultrasound-guided thoracic paravertebral block for acute herpes zoster

, , , , , & show all
Pages 369-378 | Received 04 Aug 2021, Accepted 14 Jan 2022, Published online: 02 Feb 2022

References

  • Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6):e004833.
  • Ljubojevic HS, Kovacevic M, Skerlev M, et al. Genital herpes zoster as possible indicator of HIV infection. Acta Dermatovenerol Croat. 2018;26(4):337–338.
  • Patki A, Vora A, Parikh R, et al. Herpes zoster in outpatient departments of healthcare centers in India: a review of literature. Hum Vaccin Immunother. 2021;17:1–8.
  • Gater A, Abetz-Webb L, Carroll S, et al. Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study. BMC Infect Dis. 2014;14(1):402.
  • Forbes HJ, Thomas SL, Smeeth L, et al. A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain. 2016;157(1):30–54.
  • Makharita MY. Prevention of post-herpetic neuralgia from dream to reality: a ten-step model. Pain Physician. 2017;20(2):E209–E220.
  • Makharita MY, Amr YM, El-Bayoumy Y. Single paravertebral injection for acute thoracic herpes zoster: a randomized controlled trial. Pain Pract. 2015;15(3):229–235.
  • Ji G, Niu J, Shi Y, et al. The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesth Analg. 2009;109(5):1651–1655.
  • Lee HJ, Park HS, Moon HI, et al. Effect of ultrasound-guided intercostal nerve block versus fluoroscopy-guided epidural nerve block in patients with thoracic herpes zoster: a comparative study. J Ultrasound Med. 2019;38:725–731.
  • Chen N, Li Q, Yang J, et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2014;CD006866.
  • Coplan PM, Schmader K, Nikas A, et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain. 2004;5(6):344–356.
  • Selivanova A, Buskens E, Krabbe P. Head-to-head comparison of EQ-5D-3L and EQ-5D-5L health values. Pharmacoeconomics. 2018;36(6):715–725.
  • Song H, Lee J, Lee M, et al. Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study. Int J Infect Dis. 2014;20:23–30.
  • Poquet N, Lin C. The Brief Pain Inventory (BPI). J Physiother. 2016;62(1):52.
  • Alicino C, Trucchi C, Paganino C, et al. Incidence of herpes zoster and post-herpetic neuralgia in Italy: results from a 3-years population-based study. Hum Vaccin Immunother. 2017;13(2):399–404.
  • Zheng S, Li X, Yang X, et al. Ultrasound-guided cervical nerve root block for the treatment of acute cervical herpes zoster: a randomized controlled clinical study. Pain Pract. 2019;19(5):500–509.
  • Johnson RW, Alvarez-Pasquin MJ, Bijl M, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccines. 2015;3(4):109–120.
  • Roxas M. Herpes zoster and postherpetic neuralgia: diagnosis and therapeutic considerations. Altern Med Rev. 2006;11(2):102–113.
  • Shannon HJ, Anderson J, Damle JS. Evidence for interventional procedures as an adjunct therapy in the treatment of shingles pain. Adv Skin Wound Care. 2012;25(6):276–284; quiz 285–286.
  • Xing XF, Zhou ZF, Zhang FJ, et al. The effect of early use of supplemental therapy on preventing postherpetic neuralgia: a systematic review and meta-analysis. Pain Physician. 2017;20(6):471–486.
  • Winnie AP, Hartwell PW. Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth. 1993;18(5):277–282.
  • Chun EH, Park HS. Effect of high-volume injectate in lumbar transforaminal epidural steroid injections: a randomized, active control trial. Pain Physician. 2015;18:519–525.
  • van Wijck AJ, Opstelten W, Moons KG, et al. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet. 2006;367(9506):219–224.
  • Kim HJ, Ahn HS, Lee JY, et al. Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster: a systematic review and meta-analysis. Korean J Pain. 2017;30(1):3–17.
  • Pasqualucci A, Pasqualucci V, Galla F, et al. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiol Scand. 2000;44(8):910–918.
  • Fujiwara A, Watanabe K, Hashizume K, et al. Transforaminal vs interlaminar epidural steroid injection for acute-phase shingles: a randomized, prospective trial. Pain Physician. 2018;21(4):373–382.
  • Lee HH, Park D, Oh Y, et al. Ultrasonography evaluation of vulnerable vessels around cervical nerve roots during selective cervical nerve root block. Ann Rehabil Med. 2017;41(1):66–71.
  • Huntoon MA. Anatomy of the cervical intervertebral foramina: vulnerable arteries and ischemic neurologic injuries after transforaminal epidural injections. Pain. 2005;117(1–2):104–111.
  • Mizukami A, Sato K, Adachi K, et al. Impact of herpes zoster and post-herpetic neuralgia on health-related quality of life in Japanese adults aged 60 years or older: results from a prospective, observational cohort study. Clin Drug Investig. 2018;38(1):29–37.
  • Torcel-Pagnon L, Bricout H, Bertrand I, et al. Impact of underlying conditions on zoster-related pain and on quality of life following zoster. J Gerontol A Biol Sci Med Sci. 2017;72(8):1091–1097.